期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
哌柏西利联合内分泌治疗对78例激素受体阳性HER-2阴性晚期乳腺癌的疗效观察 被引量:8
1
作者 刘宣辰 赵伟鹏 +7 位作者 史业辉 汪旭 李淑芬 郝春芳 陆宁 贾岩 王昊天 佟仲生 《中国肿瘤临床》 CAS CSCD 北大核心 2021年第5期253-257,共5页
目的:分析哌柏西利联合内分泌治疗的激素受体(hormone receptor,HR)阳性、HER-2阴性晚期乳腺癌临床疗效。方法:回顾性分析2018年9月至2019年12月78例于天津医科大学肿瘤医院行哌柏西利联合内分泌治疗HR阳性、HER-2阴性晚期乳腺癌患者的... 目的:分析哌柏西利联合内分泌治疗的激素受体(hormone receptor,HR)阳性、HER-2阴性晚期乳腺癌临床疗效。方法:回顾性分析2018年9月至2019年12月78例于天津医科大学肿瘤医院行哌柏西利联合内分泌治疗HR阳性、HER-2阴性晚期乳腺癌患者的临床资料,并对其疗效与安全性进行分析。结果:78例患者的中位年龄为58岁,中位无进展生存期(progression-free survival,PFS)为7个月,总体客观缓解率(objective response rate,ORR)为36.7%(22/60),临床获益率(clinical benefit rate,CBR)为73.3%(44/60)。既往使用解救治疗<2线和≥2线的ORR分别为71.4%(20/28)和6.3%(2/32),两者比较差异具有统计学意义(P<0.001)。采用Cox比例风险回归模型多因素分析显示,转移部位数目、既往解救治疗线数和是否行解救化疗是哌柏西利联合内分泌治疗疗效的独立影响因素。不良事件中的中性粒细胞减少为96.2%(75/78)最常见,3~4级占62.8%(49/78),14.1%(11/78)患者因3~4级的白细胞减少/中性粒细胞减少而调整用药剂量。最常见的非血液学不良事件是乏力,占23.1%(18/78)。不良事件引起的停药发生率为7.7%(6/78)。结论:哌柏西利联合内分泌治疗更适合既往解救治疗线数少、未行解救化疗的患者,较后线使用有更好的疗效,且不良事件可控。 展开更多
关键词 哌柏西利 激素受体阳性 HER-2阴性 晚期乳腺癌 内分泌治疗
下载PDF
SNX16 negatively regulates the migration and tumorigenesis of MCF-7 cells 被引量:1
2
作者 Leilei Zhang Dajiang Qin +2 位作者 chunfang hao Xiaodong Shu Duanqing Pei 《Cell Regeneration》 2013年第1期18-25,共8页
Background:Sorting nexins are a large family of proteins that are associated with various components of the endosome system and they play many roles in processes such as endocytosis,intracellular protein trafficking a... Background:Sorting nexins are a large family of proteins that are associated with various components of the endosome system and they play many roles in processes such as endocytosis,intracellular protein trafficking and cell signaling.The subcellular distribution patterns of many of them remain controversial and their in vivo functions have not been characterized yet.Results:We investigated the subcellular distribution and function of SNX16 in this study.SNX16 is detected on Rab5-positive endosomes localized adjacent to focal adhesions at cell cortex.Inhibition of SNX23,polymerization of microtubule filaments as well as the PI3-kinase all disrupt the cell cortex distribution of SNX16.Ectopic expression of SNX16 reduces the migration and the tumor formation activity of MCF-7 cells.Conclusion:Our results indicate that,in addition to the PI3P,there is a SNX23-and microtubule-dependent cargo transport pathway required for the proper subcellular distribution of SNX16.SNX16 plays a negative regulatory role during cell migration and tumorigenesis. 展开更多
关键词 TUMORIGENESIS CORTEX DISTRIBUTION
原文传递
Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019:a case report
3
作者 Kai Kang Yang Gao +15 位作者 Mingyan Zhao Dongsheng Fei Ming Ye Yan Gao Wei Yang Changsong Wang Haitao Liu Guangping Chang Xianxin Kang Yunpeng Luo Xue Du Jiping Qi Lin Tian Min Zhou chunfang hao Kaijiang Yu 《Chinese Medical Journal》 SCIE CAS CSCD 2022年第1期101-103,共3页
To the Editor:The clinical spectrum of coronavirus disease 2019(COVID-19)appears to be wide,ranging from asymptomatic to severe progressive pneumonia with respiratory failure,multiorgan failure,and even death.Here,we ... To the Editor:The clinical spectrum of coronavirus disease 2019(COVID-19)appears to be wide,ranging from asymptomatic to severe progressive pneumonia with respiratory failure,multiorgan failure,and even death.Here,we investigated the clinical and pathological characteristics of a patient who died from severe COVID-19.Our findings will facilitate a deeper understanding of the pathogenesis and progression of COVID-19 and improve clinical strategies to combat the disease.On January 23,2020,a 57-year-old man without relevant history presented with fatigue and fever after attending a family party 2 days prior.Among the members of the family party,one relative had traveled from Wuhan.Over 9 days,the fever and cough developed,and the patient visited the emergency department.A throat swab was positive for severe acute respiratory syndrome coronavirus 2(SARS-COV-2)on real-time reverse-transcription polymerase chain reaction.He was admitted to the local hospital and received supportive therapies,anti-viral agents,atomized inhalation of interferon-γ,and oxygen therapy.Cough,fever,and dyspnea further developed on February 8.He received non-invasive mechanical ventilation therapy.On February 18,he was transferred to a superior hospital with shortness of breath. 展开更多
关键词 admitted PATHOLOGICAL characteristics
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部